Nav1.7 inhibitor

CAS No. 1355631-24-1

Nav1.7 inhibitor( —— )

Catalog No. M33035 CAS No. 1355631-24-1

Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 89 In Stock
2MG 50 In Stock
5MG 82 In Stock
10MG 138 In Stock
25MG 278 In Stock
50MG 436 In Stock
100MG 700 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nav1.7 inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    Nav1.7 inhibitor is a Nav1.7 inhibitor for research in the field of pain and anesthesia.
  • Description
    Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1355631-24-1
  • Formula Weight
    426.68
  • Molecular Formula
    C15H11Cl3FNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (234.37 mM )
  • SMILES
    O=C(NS(=O)(=O)C)C=1C=C(Cl)C(=CC1F)COC2=CC=C(Cl)C(Cl)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Alan Daniel Brown, et al. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO2012007868A2.
molnova catalog
related products
  • Phenazopyridine hydr...

    Phenazopyridine hydrochloride is a local analgesic that has been used in urinary tract disorders.

  • ICA-121431

    ICA-121431 is a nanomolar potent small molecule Nav1.7 channel inhibitor with IC50 of 19 nM for rat Nav1.7 with little or no activity against human Nav1.5 or Nav1.7 channels.

  • Silperisone HCl

    Silperisone HCl (RGH-5002) blocks sodium and calcium channels in cells, decreases excitability and contractility of muscle cells, reduces peripheral tone, and acts as a muscle relaxant and peripheral vasodilator.